BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,233,000 | +81.4% | 198,832 | +54.6% | 0.00% | +100.0% |
Q4 2021 | $1,782,000 | -45.9% | 128,643 | -43.8% | 0.00% | -50.0% |
Q3 2021 | $3,292,000 | -5.3% | 229,056 | +4.1% | 0.00% | 0.0% |
Q2 2021 | $3,478,000 | +238.0% | 220,014 | +117.4% | 0.00% | +100.0% |
Q1 2021 | $1,029,000 | +63.3% | 101,189 | +19.7% | 0.00% | – |
Q4 2020 | $630,000 | +117.2% | 84,534 | +0.2% | 0.00% | – |
Q3 2020 | $290,000 | -88.8% | 84,345 | -84.4% | 0.00% | -100.0% |
Q2 2020 | $2,583,000 | +2509.1% | 542,129 | +998.1% | 0.00% | – |
Q1 2020 | $99,000 | -9.2% | 49,368 | +56.6% | 0.00% | – |
Q4 2019 | $109,000 | -32.7% | 31,519 | -44.3% | 0.00% | – |
Q3 2019 | $162,000 | +157.1% | 56,618 | +239.9% | 0.00% | – |
Q2 2019 | $63,000 | -94.0% | 16,655 | -87.1% | 0.00% | -100.0% |
Q1 2019 | $1,053,000 | +12.4% | 129,306 | +11.4% | 0.00% | 0.0% |
Q4 2018 | $937,000 | +1042.7% | 116,110 | +712.9% | 0.00% | – |
Q2 2018 | $82,000 | +34.4% | 14,284 | +10.9% | 0.00% | – |
Q1 2018 | $61,000 | +5.2% | 12,877 | +9.9% | 0.00% | – |
Q4 2017 | $58,000 | 0.0% | 11,720 | +5.9% | 0.00% | – |
Q3 2017 | $58,000 | -60.3% | 11,072 | -26.0% | 0.00% | – |
Q3 2014 | $146,000 | – | 14,960 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |